{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:53:12Z","timestamp":1785891192270,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017534","name":"Inner Mongolia Medical University","doi-asserted-by":"publisher","award":["YLXKZX-NYD-003"],"award-info":[{"award-number":["YLXKZX-NYD-003"]}],"id":[{"id":"10.13039\/100017534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017534","name":"Inner Mongolia Medical University","doi-asserted-by":"publisher","award":["MYX2023-K04"],"award-info":[{"award-number":["MYX2023-K04"]}],"id":[{"id":"10.13039\/100017534","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017534","name":"Inner Mongolia Medical University","doi-asserted-by":"publisher","award":["YKD2023BSQD002"],"award-info":[{"award-number":["YKD2023BSQD002"]}],"id":[{"id":"10.13039\/100017534","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jep.2026.122096","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:22:38Z","timestamp":1782343358000},"page":"122096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Digeda-8 formula attenuates cholestatic liver injury in rats by restoring bile acid transport and suppressing inflammation: An integrated metabolomics and proteomics approach"],"prefix":"10.1016","volume":"371","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3307-4172","authenticated-orcid":false,"given":"Alamusi","family":"Bayoude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Runa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sile","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2379-0113","authenticated-orcid":false,"given":"Batu","family":"Jirimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2026.122096_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117038","article-title":"Pirfenidone ameliorates ANIT-Induced cholestatic liver injury via modulation of FXR, NF-small ka, CyrillicB\/TNF-alpha, and Wnt\/GSK-3 beta\/beta-catenin signaling pathways","volume":"490","author":"Abdulaal","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.jep.2026.122096_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.20090","article-title":"Cellular regulation of hepatic bile acid transport in health and cholestasis","volume":"39","author":"Anwer","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.122096_bib3","article-title":"Treating 80 cases of chronic cholecystitis with Mongolian medicine Digeda-8 wei powder","volume":"39","author":"Bao","year":"2006","journal-title":"Chin. J. Ethnomed. Ethnopharmacy"},{"issue":"9","key":"10.1016\/j.jep.2026.122096_bib4","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/liv.16004","article-title":"Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice","volume":"44","author":"Brea","year":"2024","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.jep.2026.122096_bib6","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.bbrc.2014.07.023","article-title":"Inhibition of hepatitis B virus replication by SAMHD1","volume":"450","author":"Chen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jep.2026.122096_bib5","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.2147\/JIR.S430730","article-title":"The role of inflammation in cholestatic liver injury","volume":"16","author":"Chen","year":"2023","journal-title":"J. Inflamm. Res."},{"issue":"8","key":"10.1016\/j.jep.2026.122096_bib7","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"issue":"16","key":"10.1016\/j.jep.2026.122096_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165737","article-title":"Extrahepatic drug transporters in liver failure: focus on kidney and gastrointestinal tract","volume":"21","author":"Drozdzik","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.jep.2026.122096_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ph18091424","article-title":"Obeticholic acid and other Farnesoid-X-Receptor (FXR) agonists in the treatment of liver disorders","volume":"18","author":"Fiorucci","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.jep.2026.122096_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/liv.14800","article-title":"Rodent models of cholestatic liver disease: a practical guide for translational research","volume":"41","author":"Gijbels","year":"2021","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.jep.2026.122096_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.etp.2017.01.005","article-title":"Attenuation of alpha-naphthylisothiocyanate (ANIT)-Induced biliary fibrosis by depletion of hepatic macrophages in rats","volume":"69","author":"Golbar","year":"2017","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.jep.2026.122096_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118108","article-title":"Mechanistic studies on the alleviation of ANIT-Induced cholestatic liver injury by Polygala fallax hemsl. Polysaccharides","volume":"328","author":"Guan","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.jep.2026.122096_bib13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s40265-021-01545-7","article-title":"Cholestatic liver disease: current treatment strategies and new therapeutic agents","volume":"81","author":"Hasegawa","year":"2021","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jep.2026.122096_bib14","first-page":"44","article-title":"Textual research on the origin, explanation and clinical application of Mongolian medicine Digeda-8 wei powder","volume":"29","author":"Hou","year":"2023","journal-title":"Chin. J. Ethnomed. Ethnopharmacy"},{"issue":"2","key":"10.1016\/j.jep.2026.122096_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.122096_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2016.05.001","article-title":"Inhibition of hepatitis B virus replication by a dNTPase-dependent function of the host restriction factor SAMHD1","volume":"495","author":"Jeong","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.jep.2026.122096_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.018","article-title":"Drugs and hepatic transporters: a review","volume":"154","author":"Jetter","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.jep.2026.122096_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020445","article-title":"The role of COX-2 and PGE2 in the regulation of immunomodulation and other functions of mesenchymal stromal cells","volume":"11","author":"Kulesza","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jep.2026.122096_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13287-023-03342-3","article-title":"TNF-alpha\/IL-1 beta-licensed hADSCs alleviate cholestatic liver injury and fibrosis in mice via COX-2\/PGE2 pathway","volume":"14","author":"Luan","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.jep.2026.122096_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/toxsci\/kfq327","article-title":"Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury","volume":"119","author":"Luyendyk","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"19","key":"10.1016\/j.jep.2026.122096_bib21","doi-asserted-by":"crossref","first-page":"9916","DOI":"10.1039\/D4FO02158D","article-title":"Arachidonic acid enhances hepatocyte bile acid uptake and alleviates cholestatic liver disease by upregulating OATP1 expression","volume":"15","author":"Ma","year":"2024","journal-title":"Food Funct."},{"issue":"4","key":"10.1016\/j.jep.2026.122096_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/17474124.2025.2473490","article-title":"Cholestatic liver diseases: modern therapeutics","volume":"19","author":"McNally","year":"2025","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2026.122096_bib23","first-page":"1097","article-title":"Epidemiological and economical burden of cholestatic liver disease","volume":"10","author":"Mol","year":"2025","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jep.2026.122096_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.jep.2026.122096_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111678","article-title":"Recent advances on FXR-Targeting therapeutics","volume":"552","author":"Panzitt","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.jep.2026.122096_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17474124.2021.1844565","article-title":"Managing cognitive symptoms and fatigue in cholestatic liver disease","volume":"15","author":"Phaw","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2026.122096_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep26616","article-title":"Restrictive influence of SAMHD1 on hepatitis B virus life cycle","volume":"6","author":"Sommer","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jep.2026.122096_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.ph.51.030189.001113","article-title":"The role of cytoplasmic proteins in hepatic bile acid transport","volume":"51","author":"Stolz","year":"1989","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.jep.2026.122096_bib29","first-page":"3837","article-title":"The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats","volume":"17","author":"Tang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.jep.2026.122096_bib30","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-019-38668-7","article-title":"Identification of FDA-Approved drugs targeting the farnesoid X receptor","volume":"9","author":"van de Wiel","year":"2019","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.jep.2026.122096_bib31","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.7150\/ijbs.84472","article-title":"S100a16 deficiency prevents alcohol-induced fatty liver injury via inducing MANF expression in mice","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"13","key":"10.1016\/j.jep.2026.122096_bib32","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1039\/D2FO00521B","article-title":"Combination of resveratrol and luteolin ameliorates alpha-naphthylisothiocyanate-induced cholestasis by regulating the bile acid homeostasis and suppressing oxidative stress","volume":"13","author":"Wu","year":"2022","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.jep.2026.122096_bib33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.7150\/ijbs.125688","article-title":"Hepatocyte SAMHD1 deficiency attenuates hepatic steatosis via suppression of SREBP activation in a mouse model of metabolic-associated steatotic liver disease","volume":"22","author":"Yin","year":"2026","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.jep.2026.122096_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4254\/wjh.v12.i8.423","article-title":"Review: pathogenesis of cholestatic liver diseases","volume":"12","author":"Yokoda","year":"2020","journal-title":"World J. Hepatol."},{"issue":"6","key":"10.1016\/j.jep.2026.122096_bib35","first-page":"1461","article-title":"Quality study of Mongolian medicine Digeda-8 by HPLC-MS\/MS combined with chemical pattern recognition","volume":"47","author":"Zhang","year":"2024","journal-title":"J. Chin. Med. Mater."},{"key":"10.1016\/j.jep.2026.122096_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155271","article-title":"S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression","volume":"135","author":"Zhang","year":"2022","journal-title":"Metabolism"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126009505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126009505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:24:59Z","timestamp":1785889499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126009505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S0378874126009505"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.122096","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digeda-8 formula attenuates cholestatic liver injury in rats by restoring bile acid transport and suppressing inflammation: An integrated metabolomics and proteomics approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.122096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122096"}}